Jeffrey Novack - Caredx General Secretary
| CDNA Stock | USD 22.58 0.21 0.94% |
Executive
Jeffrey Novack is General Secretary of Caredx Inc
| Age | 41 |
| Phone | 415 287 2300 |
| Web | https://caredx.com |
Jeffrey Novack Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jeffrey Novack against Caredx stock is an integral part of due diligence when investing in Caredx. Jeffrey Novack insider activity provides valuable insight into whether Caredx is net buyers or sellers over its current business cycle. Note, Caredx insiders must abide by specific rules, including filing SEC forms every time they buy or sell Caredx'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jeffrey Novack over three months ago Disposition of 183 shares by Jeffrey Novack of Caredx at 15.59 subject to Rule 16b-3 | ||
Jeffrey Novack over three months ago Disposition of 1713 shares by Jeffrey Novack of Caredx at 15.42 subject to Rule 16b-3 | ||
Jeffrey Novack over six months ago Disposition of 2150 shares by Jeffrey Novack of Caredx at 37.25 subject to Rule 16b-3 |
Caredx Management Efficiency
The company has return on total asset (ROA) of (0.075) % which means that it has lost $0.075 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4302) %, meaning that it created substantial loss on money invested by shareholders. Caredx's management efficiency ratios could be used to measure how well Caredx manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Tomer BenKiki | DarioHealth Corp | 53 | |
| John Saia | Guardant Health | 51 | |
| Robert Cook | Castle Biosciences | 52 | |
| Darl Moreland | Guardant Health | 65 | |
| Austin Aerts | Sera Prognostics | 37 | |
| Limor Drezner | DarioHealth Corp | N/A | |
| Aaron Bloomer | EXACT Sciences | 38 | |
| Stephen Murphy | Guardant Health | N/A | |
| Steven Barnard | Illumina | N/A | |
| Ankur Dhingra | Illumina | 48 | |
| Nicole Berry | Illumina | N/A | |
| MD MBA | Natera Inc | N/A | |
| Joydeep MBA | Illumina | 53 | |
| Christian Haudenschild | Personalis | N/A | |
| Omar MD | DarioHealth Corp | N/A | |
| Kieran OKane | Biodesix | 47 | |
| Scott Leffler | Myriad Genetics | 49 | |
| Daniel LLM | Natera Inc | 55 | |
| Jennifer Fox | Myriad Genetics | 51 | |
| Amy Cianciaruso | Charles River Laboratories | N/A | |
| Sarah Condella | EXACT Sciences | 43 | |
Management Performance
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.075 |
Caredx Inc Leadership Team
Elected by the shareholders, the Caredx's board of directors comprises two types of representatives: Caredx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Caredx. The board's role is to monitor Caredx's management team and ensure that shareholders' interests are well served. Caredx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Caredx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marco Scheller, Senior Operations | ||
| Ian Cooney, Vice Relations | ||
| Jessica Meng, Chief Officer | ||
| Jeffrey Novack, General Secretary | ||
| Hal Gibson, Senior Planning | ||
| GS Jha, Chief VP | ||
| Reginald Seeto, President Chief Business Officer | ||
| Sasha MBA, Ex Officer | ||
| Abhishek Jain, CFO Officer | ||
| Mickey MD, Sr Product | ||
| Peter Maag, CEO and President and Director | ||
| Abraham Esq, Chief Counsel | ||
| Kashif Rathore, Head Engineering | ||
| Stacey Follon, Senior Resources | ||
| Alexander Johnson, President Services | ||
| Marcel Konrad, Sr Accounting | ||
| CPA CFA, Chief Officer | ||
| Marica Grskovic, Chief Officer | ||
| Robert Woodward, Chief Officer | ||
| John Hanna, CEO President |
Caredx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Caredx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.075 | ||||
| Profit Margin | (0.46) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 988.9 M | ||||
| Shares Outstanding | 53.63 M | ||||
| Shares Owned By Insiders | 3.43 % | ||||
| Shares Owned By Institutions | 95.98 % | ||||
| Number Of Shares Shorted | 3.45 M | ||||
| Price To Earning | (4.25) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.